News tagged with cardiac events
Related topics: patients , heart disease , heart attack , myocardial infarction
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Cardiology
9 hours ago |
5 / 5 (2) |
5
Study shows low rate of late lumen loss with bioresorbable DESolve device
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...
Cardiology
May 22, 2013 |
not rated yet |
0
Study shows that blocking an inflammation pathway prevents cardiac fibrosis
(Medical Xpress)—New research from UC Davis published in the Proceedings of the National Academy of Sciences shows that blocking an enzyme that promotes inflammation can prevent the tissue damage following a heart attack ...
Medical research
Mar 22, 2013 |
5 / 5 (5) |
0
|
Understanding a heart patients' quality of life can improve outcomes
Completing a quality-of-life questionnaire at a healthcare provider's office could help patients live longer and live better, according to a new scientific statement published in Circulation, a journal of the American Heart ...
Cardiology
May 06, 2013 |
not rated yet |
0
Duration of antiplatelet drugs for drug-eluting stents studied
(HealthDay)—In patients receiving drug-eluting stents, dual antiplatelet therapy can be safely discontinued during the first year, according to two studies published online Sept. 19 in the Journal of th ...
Cardiology
Sep 20, 2012 |
not rated yet |
0
Cardiovascular risk evaluation for all men should include assessment of sexual function
Assessment of sexual function should be incorporated into cardiovascular risk evaluation for all men, regardless of the presence or absence of known cardiovascular disease, according to Dr. Ajay Nehra, lead author of a report ...
Cardiology
Aug 30, 2012 |
5 / 5 (2) |
0
L-carnitine significantly improves patient outcomes following heart attack
L-carnitine significantly improves cardiac health in patients after a heart attack, say a multicenter team of investigators in a study published today in Mayo Clinic Proceedings. Their findings, based on analysis of key co ...
Cardiology
Apr 12, 2013 |
not rated yet |
3
Gene therapy may activate stem cells in heart failure patients
(HealthDay)—Delivery of an SDF-1 encoding plasmid (JVS-100) acts a homing signal for stem cells and improves clinical status in patients with symptomatic heart failure due to ischemic cardiomyopathy (IsCM), ...
Cardiology
Feb 22, 2013 |
not rated yet |
0
CT angiography helps predict heart attack risk
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, ...
Cardiology
Feb 19, 2013 |
not rated yet |
0
Islet transplant may slow progression of atherosclerosis
Minimally invasive islet transplantation for patients with type 1 diabetes achieves insulin independence and reverses the progression of atherosclerosis in the first few years after transplant, according to a University of ...
Diabetes
Jan 28, 2013 |
5 / 5 (2) |
0
|
Common antibiotic linked to heart problems in patients with lung conditions
The antibiotic clarithromycin – widely used for treating lower respiratory tract infections like pneumonia and acute exacerbations (sudden worsening) of chronic obstructive pulmonary disease (COPD) – may be associated ...
Medications
Mar 21, 2013 |
5 / 5 (1) |
0
Aspirin a viable treatment for recurrent, serious blood clots, study shows
(Medical Xpress)—Low-dose aspirin is a cheap and effective way to prevent potentially deadly blood clots in the leg or the lungs in patients who have had a previous blood clot, a new study shows.
Diseases, Conditions, Syndromes
Nov 05, 2012 |
4 / 5 (1) |
0
|
Use of newer-generation drug-releasing stent results in lower rate of adverse cardiac events
Compared with a bare-metal stent, the use of a stent with a biodegradable polymer that releases the drug biolimus resulted in a lower rate of major adverse cardiac events at 1 year among patients with ST-segment elevation ...
Cardiology
Aug 21, 2012 |
not rated yet |
0
Allergy to Plavix can be overcome: study
Allergies to Plavix, also know by its chemical name, Clopidogrel occur in about six percent of patients given the drug, vital for the prevention of life-threatening stent thrombosis after angioplasty and percutaneous coronary ...
Medications
Jan 16, 2012 |
not rated yet |
0
Study shows fainting factor in cardiac arrests
A new study by Dr. Andrew Krahn shows that over a quarter of unexplained cardiac arrests occurred after the patient had an event of fainting, known as syncope. According to Dr. Krahn, a Cardiologist at London Health Sciences ...
Cardiology
Feb 09, 2012 |
not rated yet |
0
